STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Oct. 28, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of company's stock-based compensation

A summary of the Company’s stock-based compensation (a component of selling, general and administrative expenses) and related income tax benefit is as follows:

(in thousands): 

	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
	October 28, 2017		October 29, 2016		October 28, 2017		October 29, 2016
Stock option expense	$	357	$	468	$	1,326	$	349
Restricted stock expense		1,074		185		3,089		1,698
ESPP expense		244		60		428		162
Total stock-based compensation	$	1,675	$	713	$	4,843	$	2,209
Income tax benefit on stock-based compensation	$	414	$	131	$	1,206	$	510

Schedule of stock option granted using the Black-Scholes option-pricing model

The fair value of each option granted during the thirteen and thirty-nine week periods ended October 28, 2017 and October 29, 2016 is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: 

	Thirteen Weeks Ended						Thirty-Nine Weeks Ended
	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Stock Options
Expected volatility		46.1	%		33.4	%		41.8	%		33.3	%
Risk-free interest rate		1.9	%		1.3	%		2.1	%		1.4	%
Expected option life (in years)		5.84			5.84			5.84			5.84
Expected dividend yield		1.98	%		1.81	%		1.87	%		1.80	%
Weighted average fair value at grant date	$	2.44		$	3.33		$	4.20		$	3.87
Employee Stock Purchase Plan
Expected volatility		86.1	%		57.4	%		82.2	%		59.0	%
Risk-free interest rate		1.0	%		0.9	%		1.0	%		0.9	%
Expected option life (in years)		0.75			0.75			0.50			0.50
Expected dividend yield		1.24	%		1.19	%		0.81	%		0.79	%
Weighted average fair value at grant date	$	7.95		$	4.01		$	6.86		$	3.74

Schedule of stock option activity

The following table summarizes stock option activity during the thirty-nine weeks ended October 28, 2017: 

	Options			Weighted-Average Exercise Price		Weighted-Average Contractual Life (years)		Aggregate Intrinsic Value (000s)
Outstanding at January 28, 2017		1,607,656		$	13.55		6.0	$	2,070
Granted		234,312			11.93
Cancelled		(275,616	)		13.29
Exercised		—			—
Outstanding at October 28, 2017		1,566,352		$	13.35		5.4		—
Exercisable at October 28, 2017		385,799		$	15.10		4.5		—

Schedule of restricted stock activity

The following table summarizes restricted stock activity during the thirty-nine weeks ended October 28, 2017:

	Number of Shares			Weighted-Average Grant Date Fair Value
Non-vested Restricted Stock at January 28, 2017		598,784		$	15.08
Granted		315,716			9.65
Forfeited / Cancelled		(39,363	)		16.00
Vested		(333,665	)		14.09
Non-vested Restricted Stock at October 28, 2017		541,472		$	12.34